Dr. Hamid Obeid, MD

NPI: 1548251663
Total Payments
$19,679
2024 Payments
$2,813
Companies
25
Transactions
507
Medicare Patients
6,401
Medicare Billing
$1.4M

Payment Breakdown by Category

Food & Beverage$12,409 (63.1%)
Travel$7,270 (36.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $12,409 486 63.1%
Travel and Lodging $7,270 21 36.9%

Top Paying Companies

Company Total Records Latest Year
Medtronic, Inc. $3,927 13 $0 (2022)
AERIN MEDICAL INC. $2,170 24 $0 (2024)
Intersect ENT, Inc. $2,111 30 $0 (2022)
Medtronic USA, Inc. $2,084 137 $0 (2020)
Acclarent, Inc $1,704 53 $0 (2023)
Entellus Medical, Inc. $1,702 15 $0 (2017)
AstraZeneca Pharmaceuticals LP $1,468 58 $0 (2024)
GlaxoSmithKline, LLC. $990.71 39 $0 (2024)
Medical Device Business Services, Inc. $826.00 7 $0 (2022)
Optinose US, Inc. $487.62 26 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,813 56 AERIN MEDICAL INC. ($1,956)
2023 $1,185 37 AstraZeneca Pharmaceuticals LP ($287.32)
2022 $5,580 53 Medtronic, Inc. ($3,891)
2021 $1,766 51 Intersect ENT, Inc. ($432.60)
2020 $826.30 62 Medtronic USA, Inc. ($240.35)
2019 $1,326 82 Medtronic USA, Inc. ($371.49)
2018 $1,218 89 Acclarent, Inc ($296.52)
2017 $4,964 77 Entellus Medical, Inc. ($1,702)

All Payment Transactions

507 individual payment records from CMS Open Payments — Page 1 of 21

Date Company Product Nature Form Amount Type
12/12/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $17.50 General
Category: Respiratory
12/05/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $19.85 General
Category: IMMUNOLOGY
12/04/2024 Ambu Inc. Food and Beverage Cash or cash equivalent $17.59 General
11/19/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $33.30 General
Category: Immunology
11/13/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $1.50 General
Category: Otolaryngology (Ear, Nose, Throat)
11/11/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $13.66 General
Category: Respiratory
11/07/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $5.37 General
Category: IMMUNOLOGY
10/15/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $24.01 General
Category: IMMUNOLOGY
10/11/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $17.64 General
Category: Respiratory
10/09/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $86.13 General
Category: IMMUNOLOGY
10/09/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device), RHINAER STYLUS Food and Beverage In-kind items and services $9.31 General
Category: EAR NOSE & THROAT
09/25/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $120.51 General
Category: Otolaryngology (Ear, Nose, Throat)
09/20/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $26.32 General
Category: IMMUNOLOGY
09/17/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $34.54 General
Category: Immunology
08/21/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $1.32 General
Category: Otolaryngology (Ear, Nose, Throat)
08/20/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.10 General
Category: Respiratory
08/14/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $13.98 General
Category: Respiratory
08/03/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $18.72 General
Category: IMMUNOLOGY
07/31/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device) Travel and Lodging Cash or cash equivalent $117.49 General
Category: EAR NOSE & THROAT
07/31/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device) Food and Beverage Cash or cash equivalent $117.15 General
Category: EAR NOSE & THROAT
07/24/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device) Travel and Lodging In-kind items and services $721.95 General
Category: EAR NOSE & THROAT
07/24/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device) Travel and Lodging In-kind items and services $253.12 General
Category: EAR NOSE & THROAT
07/24/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device) Travel and Lodging In-kind items and services $30.99 General
Category: EAR NOSE & THROAT
07/24/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device) Food and Beverage In-kind items and services $27.63 General
Category: EAR NOSE & THROAT
07/24/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device) Travel and Lodging In-kind items and services $26.93 General
Category: EAR NOSE & THROAT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 24 1,379 2,360 $698,610 $303,120
2022 29 1,644 2,641 $918,636 $416,560
2021 30 1,921 3,180 $958,786 $425,532
2020 21 1,457 2,383 $686,371 $264,394
Total Patients
6,401
Total Services
10,564
Medicare Billing
$1.4M
Procedure Codes
104

All Medicare Procedures & Services

104 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
31237 Biopsy or removal of nasal polyp or tissue using an endoscope Office 2023 92 212 $149,636 $59,271 39.6%
31298 Dilation of sphenoid and frontal nasal sinus using an endoscope Office 2023 16 16 $124,800 $58,093 46.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 334 716 $80,908 $41,888 51.8%
31231 Diagnostic exam of nasal passages using an endoscope Office 2023 162 287 $71,750 $36,953 51.5%
J3490 Unclassified drugs Office 2023 13 13 $37,206 $28,177 75.7%
31295 Dilation of nasal sinus using an endoscope Office 2023 16 16 $54,400 $27,465 50.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 80 80 $20,000 $9,617 48.1%
31238 Control of bleeding of nose using an endoscope Office 2023 17 23 $9,775 $6,330 64.8%
69145 Removal of growth in soft tissue of ear canal Office 2023 14 19 $15,783 $5,701 36.1%
31575 Diagnostic exam of voice box using a flexible endoscope Office 2023 42 49 $12,364 $4,539 36.7%
92567 Test to assess middle ear function Office 2023 152 310 $11,362 $3,755 33.1%
30520 Reshaping of nasal cartilage Office 2023 14 14 $18,720 $3,577 19.1%
69209 Removal of impacted ear wax by washing Office 2023 125 230 $17,250 $2,782 16.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 38 38 $6,650 $2,777 41.8%
30140 Removal of nasal air passage under lining tissue Office 2023 15 15 $13,936 $2,563 18.4%
70486 Ct scan of face without contrast Office 2023 34 34 $17,000 $2,010 11.8%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 42 56 $3,864 $1,862 48.2%
92570 Comprehensive hearing test Office 2023 54 54 $4,050 $1,144 28.2%
70480 Ct scan of cranial cavity without contrast Office 2023 17 17 $10,200 $1,097 10.8%
92557 Comprehensive hearing and speech recognition test Office 2023 36 36 $3,466 $849.21 24.5%
17250 Application of chemical to stop tissue regrowth in wound Office 2023 19 24 $3,798 $806.86 21.2%
30930 Therapeutic fracture of nasal passages Office 2023 15 15 $3,992 $678.00 17.0%
99152 Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes Office 2023 16 16 $4,000 $608.48 15.2%
99153 Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes Office 2023 16 70 $3,700 $576.23 15.6%
31298 Dilation of sphenoid and frontal nasal sinus using an endoscope Office 2022 27 27 $210,600 $103,203 49.0%

About Dr. Hamid Obeid, MD

Dr. Hamid Obeid, MD is a Otolaryngology healthcare provider based in Rome, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548251663.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hamid Obeid, MD has received a total of $19,679 in payments from pharmaceutical and medical device companies, with $2,813 received in 2024. These payments were reported across 507 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($12,409).

As a Medicare-enrolled provider, Obeid has provided services to 6,401 Medicare beneficiaries, totaling 10,564 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.

Practice Information

  • Specialty Otolaryngology
  • Location Rome, NY
  • Active Since 10/31/2005
  • Last Updated 09/15/2023
  • Taxonomy Code 207Y00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1548251663

Products in Payments

  • PROPEL (Device) $4,711
  • VIVAER STYLUS (Device) $2,133
  • XprESS Multi-Sinus Dilation System (Device) $1,702
  • FUSION (Device) $982.89
  • NUVENT (Device) $885.27
  • SINUVA (Drug) $826.60
  • NUCALA (Biological) $799.26
  • DUPIXENT (Biological) $758.30
  • Xhance (Drug) $487.62
  • BREZTRI (Drug) $463.70
  • ACCLARENT Balloon Inflation Device (Device) $423.61
  • SYMBICORT (Drug) $390.89
  • Acclarent Navwire (Device) $349.67
  • Otovel (Drug) $336.38
  • Acclarent Aera (Device) $298.19
  • BEVESPI AEROSPHERE (Drug) $286.38
  • ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $218.43
  • FASENRA (Biological) $188.93
  • Acclarent ENT Navigation System (Device) $160.91
  • TRELEGY ELLIPTA (Drug) $159.69

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Otolaryngology Doctors in Rome